Our results clearly demonstrated the regulation of BMP‐ACVR1 by PRC2 in B‐cell lymphoma and this signaling is critically required for the anti‐lymphoma efficacy of PRC2 inhibitors. This evidence concerns the gene ACVR1 and lymphoma.